We are live on
!
Find out more
LSC
Lesa Sroufe & Co Portfolio holdings
AUM
$140M
1-Year Est. Return
53.13%
This Fund
S&P 500
This Quarter
Est. Return
+5.05%
1 Year Est. Return
+53.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$114M
AUM Growth
+$6.32M
(+5.9%)
Cap. Flow
+$3.02M
Cap. Flow
% of AUM
2.65%
Top 10 Holdings %
Top 10 Hldgs %
44.04%
Holding
42
New
3
Increased
2
Reduced
25
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMBJ
Embraer S.A. ADS
EMBJ
|
+$2.9M |
| 2 |
Petrobras
PBR
|
+$2.05M |
| 3 |
Abercrombie & Fitch
ANF
|
+$1.84M |
| 4 |
Chevron
CVX
|
+$187K |
| 5 |
Apple
AAPL
|
+$10.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALDR
Alder Biopharmaceuticals
ALDR
|
+$1.48M |
| 2 |
Flex
FLEX
|
+$221K |
| 3 |
ORAN
Orange
ORAN
|
+$191K |
| 4 |
Banco Bilbao Vizcaya Argentaria
BBVA
|
+$152K |
| 5 |
BP
BP
|
+$133K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.6% |
| 2 | Materials | 16.85% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Energy | 8.04% |
| 5 | Communication Services | 7.09% |
Similar funds
CPC
JD6
MWM
VEM
SM
WCM
SCM
CFG
Lesa Sroufe & Co's Q3 2017 Portfolio in Review
As of Q3 2017, Lesa Sroufe & Co held 42 positions worth $114M, up 5.9% from $108M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Lesa Sroufe & Co's Q3 2017 filing shows 3 new, 2 increased, 25 reduced and 1 closed positions. Its largest new stake was Embraer S.A. ADS: 135,805 shares worth $3.07M. The largest sale was Alder Biopharmaceuticals, an estimated $1.48M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Materials and Consumer Discretionary.
- Lesa Sroufe & Co's largest Q3 2017 buy was Embraer S.A. ADS: 135,805 shares worth $3.07M.
- Lesa Sroufe & Co added most to Abercrombie & Fitch in Q3 2017, an estimated $1.84M increase.
- Lesa Sroufe & Co's biggest Q3 2017 reduction was Flex, cutting an estimated $221K.
- Lesa Sroufe & Co fully exited Alder Biopharmaceuticals in Q3 2017, selling an estimated $1.48M.
- Lesa Sroufe & Co's ten largest holdings make up 44% of its $114M portfolio in Q3 2017.
- Lesa Sroufe & Co opened 3 new positions and closed 1 in Q3 2017.
- Lesa Sroufe & Co's portfolio value rose 5.9% quarter-over-quarter to $114M.
Based on Lesa Sroufe & Co's 13F filing for Q3 2017, filed 8 Nov 2017.